|
US2020318150A1
|
|
Methods and Compositions for Improved Expression of Recombinant Proteins
|
|
WO2018187388A1
|
|
Improved purification of crm 197 from bacteria
|
|
US2016251609A1
|
|
Reduced Genome Bacteria With Improved Genetic Stability
|
|
CN107532123A
|
|
Material and method for the extension continuous stream fermentation of the bacterium of genome reduction
|
|
AU2015225439A1
|
|
Enhanced production of recombinant CRM197 in E. coli
|
|
EP3068887A1
|
|
Bacteria with improved metabolic capacity
|
|
EP2768943A1
|
|
Reduced genome bacteria with improved genetic stability
|
|
CA2751751A1
|
|
Compositions comprising reduced genome bacteria for use in treatment of sepsis
|
|
CA2736877A1
|
|
Clean genome bactofection
|
|
KR20100121642A
|
|
Compositions and methods for amino acid biosynthesis
|
|
US2011053274A1
|
|
Lac expression system
|
|
EP2167519A1
|
|
Nucleic acid packaging system
|
|
US2009068707A1
|
|
Plasmid DNA preparations and methods for producing same
|
|
WO2007124493A2
|
|
Methods and compositions for producing recombinant proteins using a gene for trna
|
|
BRPI0615578A2
|
|
Escherichia coli
|
|
MX2008003242A
|
|
Oxygen-regulated microorganisms
|
|
EP2543726A1
|
|
Reduced genome E. coli
|
